GMP Audits in Pharmaceutical and Biotechnology Industries

Mustafa Edik, after graduating as a chemist from university, began his 25-year-plus career as a laboratory supervisor at Bayer, a German pharmaceutical company. After 15 years of working as a quality assurance assistant manager, laboratory supervisor, pharmaceutical quality management systems, and GMP lead auditor, he decided to continue his career as a consultant. He served the Turkish Atomic Energy Authority (TAEA) as principal GMP auditor and consultant for six years. TAEA was audited by the Republic of Turkey's Ministry of Health and granted a GMP certificate for five radiopharmaceuticals. This success has won great acclaim from all health authorities and industry. He has prepared and presented various training courses and workshops to more than 8,000 individuals from 150 International and local pharmaceutical, medical device, and cosmetics companies on GMP, GDP, and pharmaceutical quality management systems. He has taken part in several international pharmaceutical facility establishment projects as a GMP consultant and has also set up various quality management systems for local pharmaceutical and medical device companies. While he was the vice president of quality and technical operations at Quality Academia Training and Consultancy firm, he acquired and converted it into a 100% Turkish company. As the only IRCA Certificated Pharmaceutical Quality Management Systems and GMP Lead Auditor in Turkey, he currently conducts API, excipient, packaging materials suppliers and manufacturers, third-party logistics service providers, sterile and non-sterile manufacturing facilities audits according to FDA, EMA, PIC/S, TMMDA, MHRA, TGA, Health Canada, and WHO regulations and guidelines. He completed his second university degree in biopharmaceutical sciences BSc (Hons) at Atlantic Technological University–Ireland. He is the author of a chapter in the book Good Distribution Practice: A Handbook for Healthcare Manufacturers and Suppliers, published by the Parenteral Drug Association (PDA).